The Uromigos
The Uromigos
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 133: ESMO 2021: Cabozantinib and atezolizumab in prostate cancer
27 minutes
Posted Sep 18, 2021 at 5:41 pm.
0:00
27:55
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Neeraj Agarwal describes the phase 2 study and the phase 3 plans.
Previous
Episode 132: ESMO 2021: Pembro + sEphB4-HAS in bladder cancer
Next
Episode 134: ESMO 2021: The PRISM Study
← See all 501 episodes of The Uromigos